When Phage Assays Disagree: Rebuilding the Pseudomonas aeruginosa Phagogram
Phage susceptibility tests can disagree because clearing, infectious progeny and sustained bacterial suppression measure different events. For Pseudomonas aeruginosa, these differences complicate candidate selection and the interpretation of antimicrobial-resistance trade-offs. This critical review synthesises mechanistic, assay-comparison, clinical and predictive evidence published mainly in 2020–2026. We distinguish molecular infection, population response and clinical translation, mapping common assay signals to the conclusions they support and the confirmatory measurements they require. Recent paired plaque–liquid comparisons demonstrate both achievable agreement and protocol-dependent discordance, without establishing outcome-linked clinical breakpoints. Receptor compatibility remains conditional on surface state, entry, intracellular defence and physiology. Phage resistance can alter antibiotic susceptibility in either direction; between-isolate co-resistance and selected collateral sensitivity answer different questions. Genomic and transcriptomic approaches extend candidate ranking and stage inference, but their claims remain bounded by label definition, species, data partitioning and external validation. We propose an endpoint-specific phage activity report that preserves assay conditions, productive-infection evidence, suppression, regrowth and prediction provenance. This framework uses disagreement to guide confirmation and mechanistic investigation while keeping laboratory activity distinct from treatment benefit.
Authors
- Olga V. Shneider (ORCID: https://orcid.org/0000-0001-8341-2454)
- Alexander A. Perederiy (ORCID: https://orcid.org/0000-0002-5961-1856)
- Лиознов Дмитрий Анатольевич
Publication Details
- Journal
- Preprints.org
- Published
- 2026-11-17
- DOI
- https://doi.org/10.20944/preprints202611.1629.v1
- Primary Topic
- Bacteriophages and microbial interactions
- Type
- preprint